Search Results - "Kerneis, M"

High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study by SILVAIN, Johanne, CAYLA, Guillaume, MONTALESCOT, Gilles, HULOT, Jean-Sébastien, FINZI, Jonathan, KERNEIS, Mathieu, O'CONNOR, Stephen A, BELLEMAIN-APPAIX, Anne, BARTHELEMY, Olivier, BEYGUI, Farzin, COLLET, Jean-Philippe

“…The aim of this study was to compare on-thienopyridine platelet reactivity of elderly patients (≥75 years) vs. younger patients (<75 years). Elderly patients…”
Get full text

Pulchelloid A, a sesquiterpene lactone from the Canadian prairie plant Gaillardia aristata inhibits mitosis in human cells by Bosco, Alessandra, Molina, Layla, Kernéis, Sophie M., Hatzopoulos, Georgios, Favez, Tatiana, Gönczy, Pierre, Tantapakul, Cholpisut, Maneerat, Wisanu, Yeremy, Benjamin, Williams, David E., Andersen, Raymond J., Golsteyn, Roy M.

“…Background The Canadian prairie ecosystem presents a rich source of natural products from plants that are subjected to herbivory by grazing mammals. This type…”
Get full text

Coronary thrombosis: Physiopathology and treatment in the era of tailored medicine by Zeitouni, M, Silvain, J, Kerneis, M, Guedeney, P, Overtchouk, P, Barthelemy, O, Hauguel-Moreau, M, Montalescot, G, Collet, J-P

“…Coronary thrombosis remains the leading cause for cardiovascular death in France. Great advances have been made in the knowledge of the basic mechanism…”
Get more information

CORRIGENDUM: Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry by Komajda, M, Cosentino, F, Kerneis, M

Get full text

Patients at high cardiovascular risk exhibit dysfunctional HDL particles by Materne, C., Kerneis, M., Silvain, J., Le Goff, W., Guerin, M.

Get full text

Identification of premature cardiovascular disease using a family-based strategy: a feasibility pilot study by Charleux, P, Procopi, N, Rahoual, G, Rouanet, S, Brugier, D, Barthelemy, O, Kerneis, M, Vicaut, E, Silvain, J, Montalescot, G, Zeitouni, M

“…Abstract Background Current guidelines fail to identify and effectively prevent cardiovascular disease (CVD) in young adults. Purpose To assess the feasibility…”
Get full text

Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors by Roule, V, Beygui, F, Guerin, M, Materne, C, Procopi, N, Rahoual, G, Guedeney, P, Zeitouni, M, Kerneis, M, Montalescot, G, Silvain, J

“…Abstract Background A substantial proportion of ST-segment elevation myocardial infarction (STEMI) patients has no standard modifiable cardiovascular risk…”
Get full text

Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning by Zeitouni, M, Dorvillius, E, Sulman, D, Procopi, N, Beaupre, F, Devos, P, Barthelemy, O, Rouanet, S, Ferrante, A, Chommeloux, J, Hekimian, G, Kerneis, M, Silvain, J, Montalescot, G

“…Abstract Background The role of Levosimendan in managing cardiogenic shock remains the subject of debate. Objective This study examines the use and effects of…”
Get full text

Have the ESC guidelines improved the identification and prevention of individuals at risk of premature myocardial infarction? by Zeitouni, M, Sulman, D, Silvain, J, Kerneis, M, Guedeney, P, Barthelemy, O, Procopi, N, Collet, J P, Montalescot, G

“…Abstract Background Over the last 20 years, the proportion of young patients admitted for MI has increased. It is unknown whether the 5-year changes in ESC/EAS…”
Get full text

Detection of cardiac arrhythmias following acute coronary syndrome using a connected continuous rhythm monitoring device by Charleux, P, Zeitouni, M, Procopi, N, Devos, P, Barthelemy, O, Guedeney, P, Granger, C, Ferrante, A, Laredo, M, Kerneis, M, Silvain, J, Collet, J P, Montalescot, G

“…Abstract Background The incidence of cardiac arrhythmias following acute coronary syndrome (ACS) is not well-known. Purpose To describe the incidence of…”
Get full text

Reduced capacity of HDL to acquire free cholesterol upon lipolysis of triglyceride-rich lipoproteins reflects severity of myocardial infarction by Kontush, A., Canicio, A., Ma, F., Brugier, D., Sulman, D., Lesnik, P., Zeitouni, M., Guedeney, P., Kerneis, M., Guerin, M., Le Goff, W., Collet, J.-P., Silvain, J.

Get full text

Assessment of structural and functional microvascular dysfunction using microvascular resistance reserve versus invasive exercise stress testing by Rahoual, G, Procopi, N, Beaupre, F, Martinez, C, Michon, M, Sulman, D, Guedeney, P, Hammoudi, N, Vicaut, E, Hatem, S, Kerneis, M, Silvain, J, Collet, J P, Montalescot, G, Zeitouni, M

“…Abstract Background Coronary microvascular dysfunction is an heterogenous entity with structural dysfunction present in about 60% of cases. Although Coronary…”
Get full text

Cycling coupled to intra-coronary thermodilution to evaluate angina with non-obstructive coronary artery disease by Zeitouni, M, Rahoual, G, Procopi, N, Beaupre, F, Martinez, C, Michon, M, Sulman, D, Guedeney, P, Hammoudi, N, Vicaut, E, Hatem, S, Kerneis, M, Silvain, J, Montalescot, G, Collet, J P

“…Abstract BACKGOUND Patients with Angina and Non-Obstructive Coronary Artery disease (ANOCA) face misdiagnosis and inadequate treatment. A new continuous…”
Get full text

Coronary artery disease screening in renal transplant candidates: insights from a large prospective cohort by Giovachini, L, Galichon, P, Ourahma, S, Charleux, P, Rifai, I, Redheuil, A, Drouin, S, Glasman, P, Tamzali, Y, Tourret, J, Kerneis, M, Silvain, J, Francois-Pradier, H, Montalescot, G, Zeitouni, M

“…Abstract Background There is currently no specific consensus regarding the screening strategy for CAD in renal transplant candidates. Purposes To describe in…”
Get full text

Does inflammation matter in cardiogenic shock? by Procopi, N, Sulman, D, Kerneis, M, Rouanet, S, Sbissa, Y, Beaupre, F, Devos, P, Guedeney, P, Barthelemy, O, Chommeloux, J, Hekimian, G, Combes, A, Silvain, J, Montalescot, G, Zeitouni, M

“…Abstract Background The current Society for Cardiovascular Angiography and Interventions (SCAI) shock stage classification does not include the systemic…”
Get full text

Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study by Manzo-Silberman, S, Cayla, G, Beygui, F, Range, G, Motovska, Z, Vicaut, E, Collet, J P, Guedeney, P, El Kasty, M, Kerneis, M, Zeitouni, M, Filippi, E, Coste, P, Montalescot, G, Silvain, J

“…Abstract Background The ALPHEUS trial showed a similar rate of type 4 myocardial infarction (MI) or major myocardial injury in elective PCI treated by…”
Get full text

Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients by Materne, C, Silvain, J, Zeitouni, M, Guedeney, P, Galier, S, Guillas, I, Lhomme, M, Frisdal, E, Vicaut, E, Lesnik, P, Collet, J P, Le Goff, W, Montalescot, G, Kerneis, M, Guerin, M

“…Abstract Background Low cholesterol efflux capacity and elevated levels of Interleukin-1ß (IL-1ß) are both associated with residual cardiovascular risk in…”
Get full text

Phenotyping coronary plaque by computed tomography in premature coronary artery disease by Rahoual, G, Zeitouni, M, Charpentier, E, Ritvo, P G, Rouanet, S, Procopi, N, Boukhelifa, S, Charleux, P, Guedeney, P, Kerneis, M, Barthelemy, O, Silvain, J, Montalescot, G, Collet, J P

“…Abstract Background Premature coronary artery disease (CAD) is an aggressive chronic disease with multiple recurrences mostly related to the progression or…”
Get full text

Incidence and determinants of non-radial vascular approach for coronary angiography among heart transplant recipients by Procopi, N, Guedeney, P, Zeitouni, M, Kerneis, M, Barthelemy, O, Le Feuvre, C, Silvain, J, Berman, E, Coutance, G, Varnous, S, Leprince, P, Lebreton, G, Collet, J P, Montalescot, G, Helft, G

“…Abstract Background Repeated coronary angiograms may be required among heart transplant (HT) recipients to detect coronary allograft vasculopathy (CAV),…”
Get full text

Early versus delayed introduction of renin angiotensin aldosterone system inhibitors in cardiogenic shock by Sulman, D, Zeitouni, M, Beaupre, F, Devos, P, Procopi, N, Kerneis, M, Guedeney, P, Hammoudi, N, Rouanet, S, Brugier, D, Combes, A, Hekimian, G, Collet, J P, Montalescot, G, Silvain, J

“…Abstract Background There is currently no recommendation on the appropriate timing of introduction of renin angiotensin aldosterone system inhibitors (RAASi)…”
Get full text